EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparison of the Antithrombotic Strategy Implemented to Prevent Early Recurrence before Closure of Patent Foramen Ovale

Marie Gachignard, François Derimay, Gilles Rioufol, Hélène Thibault, Muriel Rabilloud, Tae-Hee Cho, Laura Mechtouff, Laurent Derex, Elodie Ong, Julia Fontaine, Quentin Fleury, Pierre Pernot und 2 weitere

Cerebrovascular Diseases · 20.05.2026 · 1-8

DOI: 10.1159/000551034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases, online erschienen am 20.05.2026. Verfasst von Marie Gachignard und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Neurology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France, gach.marie@gmail.com. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Benefits of percutaneous patent foramen ovale (PFO) closure is demonstrated in PFO-associated stroke for secondary prevention, compared with medical treatment alone. Unfortunately, stroke recurrence can occur before PFO closure. However, no study has focused on the prevention of early cerebral ischemic recurrences that can occur before closure. The aim of our study was to compare the antithrombotic strategy implemented to prevent early cerebral ischemic recurrences before PFO closure.

Method

This is a retrospective, single-center cohort study of adult patients with ischemic stroke who underwent PFO closure at Louis Pradel Hospital in Lyon between January 3, 2020, and November 22, 2023. The primary outcome was the occurrence of an ischemic recurrence, stroke or transient ischemic attack TIA, before closure. Major bleeding represented the safety endpoint.

Results

In this retrospective cohort of 492 patients with an indication for PFO closure performed within 1 year following an ischemic stroke, 384 (78%) were under antiplatelet (APT) and 108 (22%) under anticoagulant (ACT). There were 15 early cerebral ischemic recurrences. All of these occurred under APT. Complete separation of the data prevented us to conclude with a logistic regression but suggested a significant link between APT and ischemic recurrence. No serious bleeding complication occurred.

Conclusion

Our retrospective cohort of PFO-associated stroke patients suggests that early ischemic recurrences are more frequent with APT than with ACT, with no increase in hemorrhagic risk. The antithrombotic strategy in this early time window (before PFO closure) had not been previously studied, and our results need a randomized trial for confirmation.

Schlagwörter

Stichwörter der Autor:innen

AnticoagulantAntiplateletAntithrombotic strategyEarly stroke recurrencePFO closurePatent foramen ovale

Autor:innen und Institutionen

  • Department of Vascular Neurology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France, gach.marie@gmail.com.
  • CarMeN, INSERM U1060, INRA U1397, INSA de Lyon, Université Lyon 1, Bron, France.
  • Department of Interventional Cardiology, Cardiovascular Hospital, Hospices Civils de Lyon, Lyon, France.
  • Echocardiography Lab, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France.
  • Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France.
  • CNRS UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Lyon, France.

Zitieren

APA

Gachignard, M., Derimay, F., Rioufol, G., Thibault, H., Rabilloud, M., Cho, T. H., Mechtouff, L., Derex, L., Ong, E., Fontaine, J., Fleury, Q., Pernot, P., Rascle, L., & Clottes, P. (2026). Comparison of the Antithrombotic Strategy Implemented to Prevent Early Recurrence before Closure of Patent Foramen Ovale. Cerebrovascular Diseases, 1-8. https://doi.org/10.1159/000551034

Vancouver

Gachignard M, Derimay F, Rioufol G, Thibault H, Rabilloud M, Cho TH, et al. Comparison of the Antithrombotic Strategy Implemented to Prevent Early Recurrence before Closure of Patent Foramen Ovale. Cerebrovascular Diseases. 2026:1-8. doi:10.1159/000551034

BibTeX
@article{Gachignard2026,
  author = {Gachignard, Marie and Derimay, François and Rioufol, Gilles and Thibault, Hélène and Rabilloud, Muriel and Cho, Tae-Hee and Mechtouff, Laura and Derex, Laurent and Ong, Elodie and Fontaine, Julia and Fleury, Quentin and Pernot, Pierre and Rascle, Lucie and Clottes, Paul},
  title = {Comparison of the Antithrombotic Strategy Implemented to Prevent Early Recurrence before Closure of Patent Foramen Ovale},
  journal = {Cerebrovascular Diseases},
  year = {2026},
  pages = {1--8},
  doi = {10.1159/000551034}
}
Kostenlos starten →